Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research
Konstantina G. Yiannopoulou, Aikaterini Anastasiou, Venetia Zachariou, Sigliti‐Henrietta Pelidou
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.3390/biomedicines7040097 ↗
- Volume · Issue · Pages
- 7 · 4 · 97-97
- Publisher
- MDPI AG
- Article URL
- https://doi.org/10.3390/biomedicines7040097 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
09 Dec 2019
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 09 Dec 2019 | OpenAlex |
Keywords (as given): Alzheimer's disease; disease-modifying therapy; clinical trial failure; drug development; prodromal Alzheimer's disease; preclinical Alzheimer's disease; biomarkers; amyloid; tau protein; neurofilament light chain; neurogranin; treatment goals; combination therapy; Bayesian analysis; clinical trial design; trial simulation
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- Biomedicines
- Publication date used
- 09 Dec 2019 (OpenAlex publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.